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DISCUSSION:
 •  This presentation illustrates a transformation of 
ET into AML with concurrent HLH; highlighting the 
importance of considering HLH in AML patients 
presenting with DIC, as early detection could be 
essential in managing both patients’ malignancy and 
hemodynamic status.
FOLLOW-UP:
 •  Patient was started on HLH-94 Protocol (etoposide 
and tapering steroids) along with idarubicin and 
cytarabine; subsequently platelets increased to 
37,000 and both ferritin and fibrinogen normalized. 
 •  Upon stabilization, pt was discharged and scheduled 
for follow up by Hematology Oncology at Penn State 
University for bone marrow transplant. 
Case Presentation Discussion & Follow-up
Figure A. The bone marrow biopsy is noted to 
be hypercellular. With progression of age, bone 
marrow is gradually replaced with adipose tissue. 
Considering patient’s age, approximately 20-30% of 
her bone marrow should be adipose. Presentation is 
suggestive of leukemia. 
Figure B. Under magnification. Arrows 
point to myleoblasts. Suggestive of 
acute myeloblastic leukemia (AML). 
Figure C. Anti-CD34 Stain. This stain 
tests for CD34, a cell surface protein 
found on myleoblasts. 
Figure D. Arrows point to macrophages 
phagocytosing neutrophils; note the large 
vacuoles.  Though not pathognomonic, 
such activity is suggestive of hemopha-
gocytic lymphohistiocytosis.
Bone Marrow Biopsy
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•  Hemophagocytic lymphohistiocytosis 
(HLH) is an immune system disorder 
with aberrant activation of T cells 
and macrophages resulting in 
vast tissue destruction. There 
are two forms of HLH: inherited 
HLH (autosomal recessive) and 
secondary HLH, occurring after 
strong immunologic activation. 
•  Primary HLH results from defective 
proteins involved in the cytolytic 
secretory pathway. These defective 
proteins prevent cytotoxic T 
lymphocytes and Natural Killer (NK) 
cells from maintaining immune 
homeostasis.
•  In contrast, secondary HLH 
results from upregulation of 
proinflammatory cytokines which 
results in overactivation of T 
lymphocytes and NK cells. However, 
the end result of both primary and 
secondary HLH is the same; cellular 
death and organ failure. 
•  A 56 y.o. female with a history of Essential thrombocytosis (ET) s/p hydroxyurea treatment 
presented to the ED with an episode of gross hematuria. She was hypertensive and febrile. 
Physical exam was significant for petechiae on all extremities, tachycardia, diffuse abdominal 
tenderness, and splenomegaly.
•  Considering patient’s history of ET, which has a predisposition to progress to Acute Myeloid 
Leukemia, and long term exposure to hydroxyurea (a leukemogenic agent) suspicion for leukemia 
was very high.
•  However, a low fibrinogen level indicated DIC. It wasn’t clear as to whether the DIC resulted from 
bacteremia or acute promyelocytic leukemia (APL), a variant of AML known to precipitate DIC. As 
such, a bone marrow biopsy was conducted for further analysis.  
•  However, cytogentic testing failed to reveal (15; 17) translocation; which, as a result, ruled out APL. 
•  With findings of hypercellularity and increased levels of myleoblasts in the bone marrow, a 
diagnosis of AML was made.   
•  A closer re-examination of bone marrow biopsy revealed histiophagocytic behavior (Figure D). 
Such morphological presentation raised the suspicion for HLH. As such, ferritin and triglyceride 
levels were ordered which revealed a level of >12,000 and 226, respectively. 
•  A diagnosis of HLH was made considering negative blood cultures, biopsy findings, hyper-
ferritinemia and hypofibrinoginemia.












Respiratory Rate 20 RPM
Blood Pressure 162/79 mmHg
Pulse Oxygenation 98% on room air
Laboratory Values
Lab Value
Hemoglobin 9.5 g/dL (L)
Hematocrit 27.9% (L)
WBC 10.5 (H)
RBC 3.40 mill/cmm (L)
Platelet count 12,000/cmm (LL)
RDW 21.2% (H)
Immature Cells 23% (H)
Nucleated RBC 2 per 100 WBC (H)
PT 16.5 seconds
PT INR 1.4
Fibrinogen 110 mg/dL (L)
Immature Cells 23% (H)





Hemophagocytosis Yes, see Figure D
Elevated Ferritin >12,000 (H)
Low Fibrinogen 110 mg/dL (L)
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